Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease - Ruđer Bošković Institute

Por um escritor misterioso
Last updated 06 novembro 2024
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
The goal of this project is to elucidate the molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease (NPC). We will investigate the role of protease BACE1, the key Alzheimer's disease (AD) enzyme, in the pathogenesis of NPC disease. We hope that our findings will elucidate BACE1 as a novel target for treating/ameliorating NPC disease.
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
JCM, Free Full-Text
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
Marko KOSICEK, PhD, Ruđer Bošković Institute, Zagreb
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
Marko KOSICEK, PhD, Ruđer Bošković Institute, Zagreb
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
Our research - Ruđer Bošković Institute
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
Involvement of the Choroid Plexus in the Pathogenesis of Niemann
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
The Neuropsychiatry of Niemann-Pick Type C Disease in Adulthood
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
Silva Katusic Hecimovic - Senior Scientist - Ruđer Bošković Institute
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
Jasminka ŠTEFULJ, Professor (Full), PhD
Molecular mechanism(s) of neurodegeneration in Niemann-Pick type C disease  - Ruđer Bošković Institute
PDF) Overlapping Neuroimmune Mechanisms and Therapeutic Targets in

© 2014-2024 blog.nationbloom.com. All rights reserved.